Cardiovascular Pharmacotherapy

  • Types
  • Formats
  • Years
  • Events
  • Communities
  • Special Options

Showing 24 of 1219 results

Treatment effects in contemporary cardiovascular pharmacotherapy: determinants and interpretation
ESC Journals
Treatment effects in contemporary cardiovascular pharmacotherapy: determinants and interpretation
14 July 2026
See more
Clinical outcomes of continuing vs. discontinuing oral anticoagulation after atrial fibrillation ablation: an updated systematic review and meta-analysis of observational studies and randomized controlled trials
ESC Journals
Clinical outcomes of continuing vs. discontinuing oral anticoagulation after atrial fibrillation ablation: an updated systematic review and meta-analysis of observational studies and randomized controlled trials
8 July 2026
See more
A hidden threat in the apical shadow: a case report regarding Loeffler endocarditis mimicking NSTEMI
ESC Journals
A hidden threat in the apical shadow: a case report regarding Loeffler endocarditis mimicking NSTEMI
4 July 2026
See more
Compliance to direct oral anticoagulation therapy and clinical outcomes after catheter ablation for atrial fibrillation: a nationwide cohort study
ESC Journals
Compliance to direct oral anticoagulation therapy and clinical outcomes after catheter ablation for atrial fibrillation: a nationwide cohort study
30 June 2026
See more
Early catheter ablation vs. antiarrhythmic drugs in treatment-naïve ischaemic ventricular tachyarrhythmias: a meta-analysis of randomized controlled trials
ESC Journals
Early catheter ablation vs. antiarrhythmic drugs in treatment-naïve ischaemic ventricular tachyarrhythmias: a meta-analysis of randomized controlled trials
26 June 2026
See more
Evolocumab-associated haemorrhagic pericarditis with cardiac tamponade: case report
ESC Journals
Evolocumab-associated haemorrhagic pericarditis with cardiac tamponade: case report
2 June 2026
See more
Venous vascular pharmacology: how does it contribute to heart failure with preserved ejection fraction?
ESC Journals
Venous vascular pharmacology: how does it contribute to heart failure with preserved ejection fraction?
29 May 2026
See more
ST-elevation myocardial infarction following de-escalation to aspirin monotherapy: evidence of residual platelet function MRP4 overexpression dependent case report
ESC Journals
ST-elevation myocardial infarction following de-escalation to aspirin monotherapy: evidence of residual platelet function MRP4 overexpression dependent case report
22 May 2026
See more
Stent thrombosis associated with non-response to clopidogrel despite co-administration of aspirin and ibrutinib
ESC Journals
Stent thrombosis associated with non-response to clopidogrel despite co-administration of aspirin and ibrutinib
21 May 2026
See more
Kidney function and acid–base status as gatekeepers of natriuretic and diuretic responsiveness in chronic HF: insights from the DEA-HF clinical trial
ESC Journals
Kidney function and acid–base status as gatekeepers of natriuretic and diuretic responsiveness in chronic HF: insights from the DEA-HF clinical trial
18 May 2026
See more
Selective serotonin reuptake inhibitors and bleeding risk in patients undergoing PCI on dual antiplatelet therapy: a retrospective cohort study
ESC Journals
Selective serotonin reuptake inhibitors and bleeding risk in patients undergoing PCI on dual antiplatelet therapy: a retrospective cohort study
15 May 2026
See more
Rifampicin for the treatment of a cardiogenic shock related to mavacamten toxicity: the worse and the best of drug interactions from a case report
ESC Journals
Rifampicin for the treatment of a cardiogenic shock related to mavacamten toxicity: the worse and the best of drug interactions from a case report
14 May 2026
See more
Machine learning-guided risk stratification for long QT syndrome genetic variants with hiPSC-derived cardiomyocytes
ESC Journals
Machine learning-guided risk stratification for long QT syndrome genetic variants with hiPSC-derived cardiomyocytes
14 May 2026
See more
From angiography-derived physiology guided PCI to INOCA treatment and to coronary sinus reducer: navigating multiple pathophysiological targets in a single patient: a case report
ESC Journals
From angiography-derived physiology guided PCI to INOCA treatment and to coronary sinus reducer: navigating multiple pathophysiological targets in a single patient: a case report
14 May 2026
See more
Feasibility of hypnosis for analgosedation during atrial fibrillation ablation, including pulsed field and radiofrequency techniques: a pilot study
ESC Journals
Feasibility of hypnosis for analgosedation during atrial fibrillation ablation, including pulsed field and radiofrequency techniques: a pilot study
14 May 2026
See more
Disturbed flow induced targeting of nanomedicine to endothelial cells for effective atherosclerosis therapy
ESC Journals
Disturbed flow induced targeting of nanomedicine to endothelial cells for effective atherosclerosis therapy
13 May 2026
See more
Heart failure with preserved ejection fraction subtypes: pathophysiology and treatments
Congress Session
Heart failure with preserved ejection fraction subtypes: pathophysiology and treatments
11 May 2026
See more
ePosters in pharmacology and pharmacotherapy (2)
Congress Session
ePosters in pharmacology and pharmacotherapy (2)
11 May 2026
See more
Updates in gene therapy in heart failure and cardiomyopathies
Congress Session
Updates in gene therapy in heart failure and cardiomyopathies
10 May 2026
See more
ePosters in pharmacology and pharmacotherapy (1)
Congress Session
ePosters in pharmacology and pharmacotherapy (1)
10 May 2026
See more
Controversies in contemporary drug therapy for heart failure
Congress Session
Controversies in contemporary drug therapy for heart failure
9 May 2026
See more
Proteins targeting ischaemic-reperfusion injury and repair after myocardial infarction: a systematic literature review
ESC Journals
Proteins targeting ischaemic-reperfusion injury and repair after myocardial infarction: a systematic literature review
7 May 2026
See more
Environmental risk factors and cardiovascular health A clinical consensus statement of the European Society of Cardiology
ESC Journals
Environmental risk factors and cardiovascular health A clinical consensus statement of the European Society of Cardiology
7 May 2026
See more
Effectiveness and safety of sodium-glucose cotransporter-2 inhibitor initiation in sacubitril-valsartan users with heart failure: a population-based cohort study
ESC Journals
Effectiveness and safety of sodium-glucose cotransporter-2 inhibitor initiation in sacubitril-valsartan users with heart failure: a population-based cohort study
7 May 2026
See more

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources